Document is current
Any future updates will be listed below
-
Authors
Witlox, Willem https://orcid.org/0000-0003-1007-4284
Grimm, Sabine
Howick, Jeremy
Armstrong, Nigel
Ahmadu, Charlotte
McDermott, Kevin
Otten, Thomas
Noake, Caro
Wolff, Robert
Joore, Manuela
-
Funding
Funding for this research was provided by:
Health Technology Assessment Programme
- License Information
-
More Information
Article History
Accepted: 23 March 2023
First Online: 2 May 2023
Declarations
:
: All authors have commented on the submitted manuscript and have given their approval for the final version to be published. NA, KM, JH, CA and CN critiqued the clinical effectiveness data reported and literature search conducted by the company. WW, SG, TO and MJ critiqued the mathematical model provided and the cost-effectiveness analyses submitted by the company. WW acts as overall guarantor for the article.
: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment Programme. Please visit the HTA programme website for further project information (). This summary of the ERG report was compiled after NICE issued the FAD. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of NICE or the Department of Health.
: No conflicts of interest to declare.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
